NCT01163253 2017-06-26A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisPfizerPhase 3 Terminated2,867 enrolled 77 charts